Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Free Cash Flow (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Free Cash Flow for 8 consecutive years, with $5.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Free Cash Flow fell 98.01% to $5.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $117.2 million, a 76.37% decrease, with the full-year FY2025 number at $117.2 million, down 76.37% from a year prior.
  • Free Cash Flow was $5.2 million for Q4 2025 at Select Medical Holdings, down from $122.2 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $329.6 million in Q4 2023 to a low of -$119.2 million in Q1 2024.
  • A 5-year average of $81.5 million and a median of $76.3 million in 2021 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: surged 4005.19% in 2021, then tumbled 1501.16% in 2024.
  • Select Medical Holdings' Free Cash Flow stood at -$115.9 million in 2021, then skyrocketed by 182.94% to $96.1 million in 2022, then skyrocketed by 242.89% to $329.6 million in 2023, then decreased by 20.4% to $262.4 million in 2024, then plummeted by 98.01% to $5.2 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Free Cash Flow are $5.2 million (Q4 2025), $122.2 million (Q3 2025), and $45.6 million (Q2 2025).